Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-11-22

Clinical Trial Update: Effects of High-concentration Topical Capsaicin on Histaminergic and Non-histaminergic Itch [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating high-concentration topical capsaicin for reducing pruritus; study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Capsaicin (topical, high-concentration) (capsaicin)

Snippet

Sponsor: Hjalte Holm Andersen | Conditions: Pruritus | Phase 1, Phase 2 | Status: COMPLETED